期刊的影响因子--文章列表

期刊文章列表
Xiaobei Cheng¹，Pei Yu¹，Xiang Zhou²，Jiale Zhu¹，Yubao Han¹，Chao Zhang¹，Lingyi Kong¹（State Key Laboratory of Natural Medicines，Jiangsu Key Laboratory of Bioactive Natural Product Research，School of Traditional Chinese Pharmacy，China Pharmaceutical University；Department of Science，China Pharmaceutical University）.Enhanced tumor homing of pathogen-mimicking liposomes driven by R848 stimulation：A new platform for synergistic oncology therapy[J].Acta Pharmaceutica Sinica B,2022,第2期 Mengchi Sun¹，Hailun Jiang²，Tian Liu¹，Xiao Tan¹，Qikun Jiang¹，Bingjun Sun²，Yulong Zheng³，Gang Wang⁴，Yang Wang⁴，Maosheng Cheng²，Zhonggui He¹，Jin Sun¹（Wuya College of Innovation，Shenyang Pharmaceutical University；Key Laboratory of Structure-Based Drug Design and Discovery，Shenyang Pharmaceutical University，Ministry of Education；School of Materials Science and Engineering，Ocean University of China；College of Pharmacy，Guangxi University of Chinese Medicine）.Structurally defined tandem-responsive nanoassemblies composed of dipeptide-based photosensitive derivatives and hypoxia-activated camptothecin prodrugs against primary and metastatic breast tumors[J].Acta Pharmaceutica Sinica B,2022,第2期 Xinping Kuai¹，Yuefei Zhu²，Zheng Yuan³，Shengyu Wang⁴，Lin Lin¹，Xiaodan Ye⁵，Yiping Lu¹，Yu Luo⁶，Zhiqing Pang²，Daoying Geng¹，Bo Yin¹（Department of Radiology，Huashan Hospital，Fudan University；School of Pharmacy，Fudan University，Key Laboratory of Smart Drug Delivery，Ministry of Education；Department of Radiology，Shanghai First Maternity and Infant Hospital，Tongji University School of Medicine；Department of Radiology，Ruijin Hospital，Shanghai Jiao Tong University School of Medicine；Department of Radiology，Shanghai Chest Hospital，Shanghai Jiao Tong University；State Key Laboratory of High Performance Ceramics and Superfine Microstructure，School of Chemical Science and Engineering）.Perfluorooctyl bromide nanoemulsions holding MnO₂ nanoparticles with dual-modality imaging and glutathione depletion enhanced HIFU-eliciting tumor immunogenic cell death[J].Acta Pharmaceutica Sinica B,2022,第2期 Zi Ye¹，Ke Wang¹，Lianguo Chen¹，Xiaofeng Jin¹，Hao Chen¹，Guanghui Tang²，Shao Q.Yao²，Zhiqiang Feng¹，Chong-Jing Zhang¹（State Key Laboratory of Bioactive Substances and Functions of Natural Medicines and Beijing Key Laboratory of Active Substances Discovery and Drugability Evaluation，Institute of Materia Medica Peking Union Medical College and Chinese Academy of Medical Sciences；Department of Chemistry，National University of Singapore）.A targeted covalent inhibitor of p97 with proteome-wide selectivity[J].Acta Pharmaceutica Sinica B,2022,第2期 Hong Chen¹，Lijun Sun¹，Lu Feng¹，Michael Mulholland²，Weizhen Zhang^1,2，Yue Yin¹（Department of Physiology and Pathophysiology，School of Basic Medical Sciences，Key Laboratory of Molecular Cardiovascular Science，Ministry of Education，Peking University；Department of Surgery，University of Michigan Medical Center）.Peptidoglycan inhibits beigeing of adipose tissue[J].Acta Pharmaceutica Sinica B,2022,第2期（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].药学学报(英文版),2022,第2期 Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2022,第2期 Jincheng Wang¹，Kaili Hu^1,2，Xuanyan Cai¹，Bo Yang²，Qiaojun He^1,2，Jiajia Wang¹，Qinjie Weng^1,2（Center for Drug Safety Evaluation and Research，College of Pharmaceutical Sciences，Zhejiang University；Hangzhou Institute of Innovative Medicine，College of Pharmaceutical Sciences，Zhejiang University）.Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis[J].Acta Pharmaceutica Sinica B,2022,第1期 Patrick Kwabena Oduro¹，Xianxian Zheng¹，Jinna Wei¹，Yanze Yang¹，Yuefei Wang^1,2，Han Zhang^1,2，Erwei Liu^1,2，Xiumei Gao^1,2，Mei Du³，Qilong Wang^1,2（Institute of Traditional Chinese Medicine，Tianjin University of Traditional Chinese Medicine；State Key Laboratory of Component-Based Chinese Medicine，Ministry of Education；Department of Pharmacology and Tianjin Key Laboratory of Inflammation Biology，School of Basic Medical Sciences，Tianjin Medical University）.The cGAS-STING signaling in cardiovascular and metabolic diseases：Future novel target option for pharmacotherapy[J].Acta Pharmaceutica Sinica B,2022,第1期 Katherine Byrnes，Sophia Blessinger，Niani Tiaye Bailey，Russell Scaife，Gang Liu，Bilon Khambu（Department of Pathology and Laboratory Medicine，Tulane University School of Medicine）.Therapeutic regulation of autophagy in hepatic metabolism[J].Acta Pharmaceutica Sinica B,2022,第1期 Shuwen Fu¹，Guanting Li²，Wenli Zang³，Xinyu Zhou⁴，Kexin Shi⁵，Yinglei Zhai⁵（School of Pharmacy，Shenyang Pharmaceutical University；Department of Pharmaceutics，Wuya College of Innovation，Shenyang Pharmaceutical University；Department of Periodontology，School and Hospital of Stomatology，China Medical University，Liaoning Provincial Key Laboratory of Oral Disease；Bio-system Pharmacology，Graduate School of Medicine，Faculty of Medicine，Osaka University；Department of Biomedical Engineering，School of Medical Device，Shenyang Pharmaceutical University）.Pure drug nano-assemblies：A facile carrier-free nanoplatform for efficient cancer therapy[J].Acta Pharmaceutica Sinica B,2022,第1期 Dandan Sun¹，Yifang Zou¹，Liu Song¹，Shulan Han¹，Hao Yang¹，Di Chu¹，Yun Dai²，Jie Ma¹，Caitriona M.O'Driscoll³，Zhuo Yu⁴，Jianfeng Guo¹（School of Pharmaceutical Sciences，Jilin University；Laboratory of Cancer Precision Medicine，The First Hospital of Jilin University；Pharmacodelivery Group，School of Pharmacy，University College Cork；Department of Hepatopathy，Shuguang Hospital，Affiliated to Shanghai University of Traditional Chinese Medicine）.A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer[J].Acta Pharmaceutica Sinica B,2022,第1期 Lei Luo¹，Yiming Qi¹，Hong Zhong¹，Shinan Jiang¹，Hu Zhang²，Hao Cai³，Yahui Wu³，Zhongwei Gu³，Qiyong Gong^3,4，Kui Luo³（College of Pharmaceutical Sciences，Southwest University；Amgen Bioprocessing Centre，Keck Graduate Institute；Huaxi MR Research Center (HMRRC)，Department of Radiology，Functional and Molecular Imaging Key Laboratory of Sichuan Province，National Clinical Research Center for Geriatrics，West China Hospital，Sichuan University；Research Unit of Psychoradiology，Chinese Academy of Medical Sciences）.GSH-sensitive polymeric prodrug：Synthesis and loading with photosensitizers as nanoscale chemo-photodynamic anti-cancer nanomedicine[J].Acta Pharmaceutica Sinica B,2022,第1期 Jinjing Wei¹，Yongting Zhao²，Haihai Liang³，Weijie Du³，Lihong Wang¹（Department of Endocrinology，the First Affiliated Hospital of Jinan University；Department of Endocrinology，the Second Affiliated Hospital of Harbin Medical University；Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China，Key Laboratory of Cardiovascular Research，Ministry of Education)，College of Pharmacy，Harbin Medical University）.Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy[J].Acta Pharmaceutica Sinica B,2022,第1期 Qianqian Li¹，Zhaoqing Shi¹，Fan Zhang¹，Weiwei Zeng¹，Dunwan Zhu²，Lin Mei²（School of Pharmaceutical Sciences (Shenzhen)，Sun Yat-sen University；Tianjin Key Laboratory of Biomedical Materials，Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy，Institute of Biomedical Engineering，Chinese Academy of Medical Sciences & Peking Union Medical College）.Symphony of nanomaterials and immunotherapy based on the cancer-immunity cycle[J].Acta Pharmaceutica Sinica B,2022,第1期 Wenjuan Liu¹，Zhenqiang Li¹，Simeng Chu¹，Xiaoyao Ma¹，Xiaoying Wang²，Min Jiang¹，Gang Bai¹（State Key Laboratory of Medicinal Chemical Biology，College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research，Nankai University；Tianjin University of Traditional Chinese Medicine）.Atractylenolide-I covalently binds to CYP11B2,selectively inhibits aldosterone synthesis, and improves hyperaldosteronism[J].Acta Pharmaceutica Sinica B,2022,第1期 Jian Gao¹，Zhigui Wu¹，Mingxia Zhao^1,2，Rui Zhang³，Manru Li¹，Dongdong Sun⁴，Haibo Cheng⁴，Xianjia Qi⁵，Yuxian Shen²，Qiang Xu^1,6，Hongqi Chen⁷，Dijun Chen¹，Yang Sun^1,6（State Key Laboratory of Pharmaceutical Biotechnology，Chemistry and Biomedicine Innovation Center(Chem BIC)，School of Life Sciences，Nanjing University；Biopharmaceutical Research Institute，School of Basic Medical Sciences，Anhui Medical University；Department of Colorectal Surgery，Cancer Hospital of China Medical University，Liaoning Cancer Hospital & Institute；The First Clinical College of Nanjing University of Chinese Medicine；Shanghai Xu Ran Biotechnology Co.，Ltd.；Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy，Xuzhou Medical University；Department of General Surgery，Shanghai Jiao Tong University Affiliated Sixth People's Hospital）.Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics[J].Acta Pharmaceutica Sinica B,2022,第1期 Qi Hu^1,2，Lanlan Jia^1,2，Xiaolin Zhang^1,2，Aihong Zhu^1,2，Sicen Wang^1,2，Xiaoyu Xie^1,2（School of Pharmacy，Health Science Center，Xi'an Jiaotong University；Shaanxi Engineering Research Center of Cardiovascular Drugs Screening & Analysis）.Accurate construction of cell membrane biomimetic graphene nanodecoys via purposeful surface engineering to improve screening efficiency of active components of traditional Chinese medicine[J].Acta Pharmaceutica Sinica B,2022,第1期 Shuangquan Gou^1,2,3，Nanxi Chen²，Xiaoai Wu⁴，Menghang Zu^2,3，Shixiong Yi²，Binwu Ying⁵，Fangyin Dai²，Bowen Ke¹，Bo Xiao^2,3（Laboratory of Anesthesiology & Critical Care Medicine，Department of Anesthesiology，West China Hospital，Sichuan University；State Key Laboratory of Silkworm Genome Biology，College of Sericulture，Textile and Biomass Sciences，Southwest University；Chongqing Key Laboratory of Soft-Matter Material Chemistry and Function Manufacturing，School of Materials and Energy，Southwest University；Department of Nuclear Medicine，West China Hospital，Sichuan University；Department of Laboratory Medicine，West China Hospital，Sichuan University）.Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy[J].Acta Pharmaceutica Sinica B,2022,第1期 Xianbin Ma¹，Shaochen Yang²，Tian Zhang¹，Shuo Wang²，Qichao Yang²，Yao Xiao²，Xiaoxiao Shi³，Peng Xue¹，Yuejun Kang¹，Gang Liu³，Zhi-Jun Sun²，Zhigang Xu¹（Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University)，Ministry of Education，School of Materials and Energy & Chongqing Engineering Research Center for Micro-Nano Biomedical Materials and Devices，Southwest University；The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine，Ministry of Education，School and Hospital of Stomatology，Wuhan University；State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics & Center for Molecular Imaging and Translational Medicine，School of Public Health，Xiamen University）.Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2022,第1期 Rong Guo，Miao Deng，Xuan He，Mengmeng Li，Jiaxin Li，Penghui He，Houqin Liu，Man Li，Zhirong Zhang，Qin He（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Fucoidan-functionalized activated platelet-hitchhiking micelles simultaneously track tumor cells and remodel the immunosuppressive microenvironment for efficient metastatic cancer treatment[J].Acta Pharmaceutica Sinica B,2022,第1期 Zhenhao Tian^1,2,3，Fei Yan¹，Xiangge Tian^1,2，Lei Feng^1,4，Jingnan Cui⁵，Sa Deng¹，Baojing Zhang¹，Tian Xie⁶，Shanshan Huang¹，Xiaochi Ma^1,2（Dalian Key Laboratory of Metabolic Target Characterization and Traditional Chinese Medicine Intervention，The Second Affiliated Hospital，College of Integrative Medicine，College of Pharmacy，Dalian Medical University；Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy，Xuzhou Medical University；School of Life Sciences，Northwestern Polytechnical University；School of Chemistry and Chemical Engineering，Henan Normal University；State Key Laboratory of Fine Chemicals，Dalian University of Technology；College of Pharmacy，Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines，Hangzhou Normal University）.A NIR fluorescent probe for Vanin-1 and its applications in imaging, kidney injury diagnosis,and the development of inhibitor[J].Acta Pharmaceutica Sinica B,2022,第1期 Long Xi¹，Zibei Lin¹，Fen Qiu¹，Shaokui Chen¹，Ping Li²，Xin Chen¹，Zhenping Wang³，Ying Zheng¹（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau；Beijing Hospital of Traditional Chinese Medicine，Affiliated with Capital Medical University；Department of Dermatology，School of Medicine，University of California）.Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment[J].Acta Pharmaceutica Sinica B,2022,第1期 Benyu Nan^1,2，Zirui Zhao³，Kanglun Jiang¹，Xi Gu⁴，Huawei Li^5,6,7,8，Xinsheng Huang¹（Department of Otorhinolaryngology-Head and Neck Surgery，Zhongshan Hospital，Fudan University；Department of Otorhinolaryngology-Head and Neck Surgery，Wenzhou Medical University，Affiliated Hospital 2；Department of Otolaryngology，Yueyang Hospital of Integrated Traditional Chinese and Western Medicine，Shanghai University of Traditional Chinese Medicine；Department of Otolaryngology，the First Affiliated Hospital of Fujian Medical University；ENT Institute and Department of Otorhinolaryngology，Eye & ENT Hospital，State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science，Fudan University；Institutes of Biomedical Sciences，Fudan University；NHC Key Laboratory of Hearing Medicine (Fudan University)；The Institutes of Brain Science and the Collaborative Innovation Center for Brain Science，Fudan University）.Astaxanthine attenuates cisplatin ototoxicity in vitro and protects against cisplatin-induced hearing loss in vivo[J].Acta Pharmaceutica Sinica B,2022,第1期 Rui Li¹，Li Xie¹，Lei Li¹，Xiaojiao Chen²，Tong Yao¹，Yuanxin Tian³，Qingping Li⁴，Kai Wang⁴，Chenyang Huang¹，Cui Li¹，Yifan Li¹，Hongwei Zhou²，Neil Kaplowitz⁵，Yong Jiang¹，Peng Chen^1,2（Department of Pathophysiology，Guangdong Provincial Key Laboratory of Proteomics，School of Basic Medical Sciences，Southern Medical University；Microbiome Medicine Center，Zhujiang Hospital，Southern Medical University；Guangdong Provincial Key Laboratory of New Drug Screening，School of Pharmaceutical Science，Southern Medical University；Division of Hepatobiliopancreatic Surgery，Department of General Surgery，Nanfang Hospital，Southern Medical University；USC Research Center for Liver Disease，Department of Medicine，Keck School of Medicine of USC）.The gut microbial metabolite, 3,4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice[J].Acta Pharmaceutica Sinica B,2022,第1期首页上一页 9 10 11 12 下一页尾页共有12页，转到页

期刊文章列表